120 related articles for article (PubMed ID: 25016062)
1. Functional characterisation of different MLL fusion proteins by using inducible Sleeping Beauty vectors.
Wächter K; Kowarz E; Marschalek R
Cancer Lett; 2014 Oct; 352(2):196-202. PubMed ID: 25016062
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential.
Emerenciano M; Kowarz E; Karl K; de Almeida Lopes B; Scholz B; Bracharz S; Meyer C; Pombo-de-Oliveira MS; Marschalek R
Cancer Lett; 2013 May; 332(1):30-4. PubMed ID: 23340173
[TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants.
Strehl S; König M; Meyer C; Schneider B; Harbott J; Jäger U; von Bergh AR; Loncarevic IF; Jarosova M; Schmidt HH; Moore SD; Marschalek R; Haas OA
Genes Chromosomes Cancer; 2006 Nov; 45(11):1041-9. PubMed ID: 16897742
[TBL] [Abstract][Full Text] [Related]
4. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
Wang QF; Wu G; Mi S; He F; Wu J; Dong J; Luo RT; Mattison R; Kaberlein JJ; Prabhakar S; Ji H; Thirman MJ
Blood; 2011 Jun; 117(25):6895-905. PubMed ID: 21518926
[TBL] [Abstract][Full Text] [Related]
5. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23).
Nemoto N; Suzukawa K; Shimizu S; Shinagawa A; Takei N; Taki T; Hayashi Y; Kojima H; Kawakami Y; Nagasawa T
Genes Chromosomes Cancer; 2007 Sep; 46(9):813-9. PubMed ID: 17551948
[TBL] [Abstract][Full Text] [Related]
7. The reciprocal world of MLL fusions: A personal view.
Marschalek R
Biochim Biophys Acta Gene Regul Mech; 2020 Jul; 1863(7):194547. PubMed ID: 32294539
[TBL] [Abstract][Full Text] [Related]
8. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4.
Liu H; Westergard TD; Cashen A; Piwnica-Worms DR; Kunkle L; Vij R; Pham CG; DiPersio J; Cheng EH; Hsieh JJ
Cancer Cell; 2014 Apr; 25(4):530-42. PubMed ID: 24735925
[TBL] [Abstract][Full Text] [Related]
10. MLL leukemia and future treatment strategies.
Marschalek R
Arch Pharm (Weinheim); 2015 Apr; 348(4):221-8. PubMed ID: 25740345
[TBL] [Abstract][Full Text] [Related]
11. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
12. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
[TBL] [Abstract][Full Text] [Related]
13. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.
Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D
Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759
[TBL] [Abstract][Full Text] [Related]
14. Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?
Somervaille TC; Cleary ML
Int J Hematol; 2010 Jun; 91(5):735-41. PubMed ID: 20454944
[TBL] [Abstract][Full Text] [Related]
15. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
[TBL] [Abstract][Full Text] [Related]
16. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21).
Strehl S; Borkhardt A; Slany R; Fuchs UE; König M; Haas OA
Oncogene; 2003 Jan; 22(1):157-60. PubMed ID: 12527918
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.
Gaussmann A; Wenger T; Eberle I; Bursen A; Bracharz S; Herr I; Dingermann T; Marschalek R
Oncogene; 2007 May; 26(23):3352-63. PubMed ID: 17130830
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of leukemogenesis by MLL fusion proteins.
Marschalek R
Br J Haematol; 2011 Jan; 152(2):141-54. PubMed ID: 21118195
[TBL] [Abstract][Full Text] [Related]
19. AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription.
Okuda H; Kanai A; Ito S; Matsui H; Yokoyama A
Nat Commun; 2015 Nov; 6():8869. PubMed ID: 26593443
[TBL] [Abstract][Full Text] [Related]
20. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.
Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R
Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]